In 2018–2019, data on antimicrobial resistance in zoonotic and indicator bacteria, submitted by 28 EU Member States (MSs), were jointly analysed by the EFSA and the ECDC.
The number of reported human cases of illness caused by Campylobacter and Salmonella bacteria across Europe appears to have stabilised over the past five years, according to the latest report on zoonotic diseases by EFSA and ECDC.
This report of the EFSA and ECDC presents the results of zoonoses monitoring activities carried out in 2019 in 36 European countries (28 Member States (MS) and eight non-MS).
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period 3-9 January 2021 and includes updates on COVID-19, yellow fever, and influenza.
This report presents the results of the ninth round of the external quality assessment (EQA-9) scheme for typing of Shiga toxin-producing Escherichia coli (STEC).
This report provides an analysis of the external quality assessment (EQA) for the antimicrobial susceptibility testing (AST) performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2019. A total of 952 laboratories (1–95 per country) from 30 EU/EEA countries participated in the EQA exercise.
For 2018, EU/EEA countries reported 13 travel-related cases of yellow fever. The cases were reported by France (7), Germany (2), Czechia (1), the Netherlands (1), Romania (1) and the United Kingdom(1). The case reported by the Netherlands acquired the infection in Senegal or Gambia. All other cases acquired the infection in Brazil. This was the highest number of yellow fever cases ever reported in the EU/EEA in one year. In the previous four years, only one case was reported: the Netherlands reported an imported case with a travel history to Suriname.